Europe – Kheiron Medical launches trial of AI algorithm for breast cancer Dx

Kheiron’s test in England aimed at helping hospitals cope with shortage of radiologists.

Several European companies have trained artificial intelligence to detect signs of breast cancer, in the hope that a breakthrough will help hospitals contending with a shortage of radiologists. Kheiron Medical is the latest company to announce that it will use AI algorithms to try to diagnose breast cancer, launching a trial on historic scans this month at a National Health Service trust in Leeds in the north of England. Its technology will also be tested against tens of thousands of historic scans in the East Midlands to see whether it can identify signs of breast cancer. DeepMind, the AI company owned by Google, has also recently begun a trial with the NHS, while Dutch company ScreenPoint Medical has developed similar technology. The companies are testing their algorithms on tens of thousands of mammograms to see whether they can train them to identify signs of breast cancer as competently as human radiologists. Kheiron’s algorithm has been trained on half a million scans from hospitals in Hungary. The start-up has already submitted its findings for peer review after concluding that its technology “beat the average performance of a human radiologist” when tested against 3,500 scans, according to clinical director Hugh Harvey…